{"id":441862,"date":"2021-02-23T08:33:17","date_gmt":"2021-02-23T13:33:17","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=441862"},"modified":"2021-02-23T08:33:17","modified_gmt":"2021-02-23T13:33:17","slug":"chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/","title":{"rendered":"ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call\u00a0on Monday, March 1, 2021"},"content":{"rendered":"
\n

MOUNTAIN VIEW, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) — ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company’s fourth quarter and full year 2020 financial results will be released after market close on Monday, March 1, 2021. ChemoCentryx executive management will host a conference call and webcast beginning at 5:00 p.m. Eastern Time on March 1, 2021 to discuss these results and to answer questions.<\/p>\n

To participate by telephone, please dial (877) 303-8028 (Domestic) or (760) 536-5167 (International). The conference ID number is 8283128. A live and archived audio webcast can be accessed through the Investors section of the Company’s website at www.ChemoCentryx.com. The archived webcast will remain available on the Company’s website for fourteen (14) days following the call.<\/p>\n

\n About ChemoCentryx <\/strong>
\n
ChemoCentryx is a biopharmaceutical company developing new medications for inflammatory and autoimmune diseases and cancer. ChemoCentryx targets the chemokine and chemoattractant systems to discover, develop and commercialize orally administered therapies. ChemoCentryx\u2019s lead drug candidate, avacopan (CCX168), successfully completed a pivotal Phase III trial in ANCA-associated vasculitis and a New Drug Application is under review by the U.S. Food and Drug Administration. Avacopan is also in late-stage clinical development for the treatment of severe Hidradenitis Suppurativa and C3 glomerulopathy (C3G).<\/p>\n

ChemoCentryx also has early-stage drug candidates that target chemoattractant receptors in other inflammatory and autoimmune diseases and in cancer.<\/p>\n

\n Contacts:<\/strong>\n <\/p>\n

Susan M. Kanaya
Executive Vice President,
Chief Financial and Administrative Officer
investor@chemocentryx.com<\/a>\u00a0<\/p>\n

Media:
Stephanie Tomei
408.234.1279
media@chemocentryx.com<\/a><\/p>\n

Investors:
Lee Roth, Burns McClellan
212.213.0006
lroth@burnsmc.com<\/a><\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

MOUNTAIN VIEW, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) — ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company’s fourth quarter and full year 2020 financial results will be released after market close on Monday, March 1, 2021. ChemoCentryx executive management will host a conference call and webcast beginning at 5:00 p.m. Eastern Time on March 1, 2021 to discuss these results and to answer questions. To participate by telephone, please dial (877) 303-8028 (Domestic) or (760) 536-5167 (International). The conference ID number is 8283128. A live and archived audio webcast can be accessed through the Investors section of the Company’s website at www.ChemoCentryx.com. The archived webcast will remain available on the Company’s website for fourteen (14) days following the call. … <\/p>\n

Continue reading “ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call\u00a0on Monday, March 1, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-441862","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call\u00a0on Monday, March 1, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call\u00a0on Monday, March 1, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MOUNTAIN VIEW, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) — ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company’s fourth quarter and full year 2020 financial results will be released after market close on Monday, March 1, 2021. ChemoCentryx executive management will host a conference call and webcast beginning at 5:00 p.m. Eastern Time on March 1, 2021 to discuss these results and to answer questions. To participate by telephone, please dial (877) 303-8028 (Domestic) or (760) 536-5167 (International). The conference ID number is 8283128. A live and archived audio webcast can be accessed through the Investors section of the Company’s website at www.ChemoCentryx.com. The archived webcast will remain available on the Company’s website for fourteen (14) days following the call. … Continue reading "ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call\u00a0on Monday, March 1, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-23T13:33:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzQzOCMzOTg4OTM3IzIwMDY0MDc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call\u00a0on Monday, March 1, 2021\",\"datePublished\":\"2021-02-23T13:33:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\\\/\"},\"wordCount\":257,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzQzOCMzOTg4OTM3IzIwMDY0MDc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\\\/\",\"name\":\"ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call\u00a0on Monday, March 1, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzQzOCMzOTg4OTM3IzIwMDY0MDc=\",\"datePublished\":\"2021-02-23T13:33:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzQzOCMzOTg4OTM3IzIwMDY0MDc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzQzOCMzOTg4OTM3IzIwMDY0MDc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call\u00a0on Monday, March 1, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call\u00a0on Monday, March 1, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/","og_locale":"en_US","og_type":"article","og_title":"ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call\u00a0on Monday, March 1, 2021 - Market Newsdesk","og_description":"MOUNTAIN VIEW, Calif., Feb. 23, 2021 (GLOBE NEWSWIRE) — ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company’s fourth quarter and full year 2020 financial results will be released after market close on Monday, March 1, 2021. ChemoCentryx executive management will host a conference call and webcast beginning at 5:00 p.m. Eastern Time on March 1, 2021 to discuss these results and to answer questions. To participate by telephone, please dial (877) 303-8028 (Domestic) or (760) 536-5167 (International). The conference ID number is 8283128. A live and archived audio webcast can be accessed through the Investors section of the Company’s website at www.ChemoCentryx.com. The archived webcast will remain available on the Company’s website for fourteen (14) days following the call. … Continue reading \"ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call\u00a0on Monday, March 1, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-23T13:33:17+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzQzOCMzOTg4OTM3IzIwMDY0MDc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call\u00a0on Monday, March 1, 2021","datePublished":"2021-02-23T13:33:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/"},"wordCount":257,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzQzOCMzOTg4OTM3IzIwMDY0MDc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/","name":"ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call\u00a0on Monday, March 1, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzQzOCMzOTg4OTM3IzIwMDY0MDc=","datePublished":"2021-02-23T13:33:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzQzOCMzOTg4OTM3IzIwMDY0MDc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzQzOCMzOTg4OTM3IzIwMDY0MDc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/chemocentryx-to-hold-fourth-quarter-and-full-year-2020-financial-results-conference-call-on-monday-march-1-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ChemoCentryx to Hold Fourth Quarter and Full Year 2020 Financial Results Conference Call\u00a0on Monday, March 1, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441862","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=441862"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441862\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=441862"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=441862"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=441862"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}